Over the past five trading sessions, Oklo shares have delivered a cumulative gain of 36%, driving the company’s market capitalization up by approximately $3.9 billion to reach $15 billion. This marks the longest winning streak for the next-generation nuclear specialist since its public debut, with average daily volume climbing to 15 million shares, reflecting heightened investor interest in advanced fission technologies and the firm’s near-term growth prospects.

Oklo has entered into an Other Transaction Agreement with the U.S. Department of Energy to design, construct and operate a radioisotope pilot plant under the DOE Reactor Pilot Program. The pilot facility will be managed by Oklo’s subsidiary Atomic Alchemy, focusing on domestic production of medical and research radioisotopes that are currently sourced overseas. While financial terms remain undisclosed, the contract represents a major milestone in Oklo’s strategy to streamline regulatory approvals, generate operational data and de-risk future commercial deployments of its fast fission technology.

Oklo’s Aurora fast reactor leverages decades-old nuclear systems, combining high-assay low-enriched uranium fuel with passive safety mechanisms to achieve continuous operation without on-site refueling for up to five years. The design also incorporates an integral fuel recycling module capable of converting spent fuel into new fuel feedstock, potentially reducing long-lived nuclear waste by more than 90%. Management projects that commercialization of this technology could support baseload power contracts in multiple U.S. markets and create a domestic supply chain for advanced reactor fuel.